FI64576C - Foerfarande foer framstaellning av en terapeutiskt anvaendbar somatostatinanalog - Google Patents

Foerfarande foer framstaellning av en terapeutiskt anvaendbar somatostatinanalog Download PDF

Info

Publication number
FI64576C
FI64576C FI781184A FI781184A FI64576C FI 64576 C FI64576 C FI 64576C FI 781184 A FI781184 A FI 781184A FI 781184 A FI781184 A FI 781184A FI 64576 C FI64576 C FI 64576C
Authority
FI
Finland
Prior art keywords
resin
acid
somatostatin
minutes
val
Prior art date
Application number
FI781184A
Other languages
English (en)
Finnish (fi)
Other versions
FI781184A (fi
FI64576B (fi
Inventor
James Edwin Shields
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI781184A publication Critical patent/FI781184A/fi
Application granted granted Critical
Publication of FI64576B publication Critical patent/FI64576B/fi
Publication of FI64576C publication Critical patent/FI64576C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/28—Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI781184A 1977-04-21 1978-04-18 Foerfarande foer framstaellning av en terapeutiskt anvaendbar somatostatinanalog FI64576C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/789,472 US4100117A (en) 1977-04-21 1977-04-21 Somatostatin analogs and intermediates thereto
US78947277 1977-04-21

Publications (3)

Publication Number Publication Date
FI781184A FI781184A (fi) 1978-10-22
FI64576B FI64576B (fi) 1983-08-31
FI64576C true FI64576C (fi) 1983-12-12

Family

ID=25147748

Family Applications (1)

Application Number Title Priority Date Filing Date
FI781184A FI64576C (fi) 1977-04-21 1978-04-18 Foerfarande foer framstaellning av en terapeutiskt anvaendbar somatostatinanalog

Country Status (31)

Country Link
US (1) US4100117A (fr)
JP (1) JPS53132588A (fr)
AR (1) AR221699A1 (fr)
AT (1) AT361142B (fr)
AU (1) AU519275B2 (fr)
BE (1) BE866117A (fr)
BG (1) BG28703A3 (fr)
CA (2) CA1102315A (fr)
CH (1) CH634039A5 (fr)
CS (1) CS202096B2 (fr)
DD (1) DD135900A5 (fr)
DE (1) DE2816854A1 (fr)
DK (1) DK174278A (fr)
ES (2) ES469005A1 (fr)
FI (1) FI64576C (fr)
FR (1) FR2387941A1 (fr)
GB (1) GB1596328A (fr)
GR (1) GR68945B (fr)
HU (1) HU177435B (fr)
IE (1) IE46868B1 (fr)
IL (1) IL54533A (fr)
IT (1) IT1094462B (fr)
NL (1) NL7804218A (fr)
NZ (1) NZ187009A (fr)
PL (2) PL114533B1 (fr)
PT (1) PT67913B (fr)
RO (2) RO76054A (fr)
SE (1) SE7804397L (fr)
SU (2) SU730295A3 (fr)
YU (1) YU91578A (fr)
ZA (1) ZA782247B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202802A (en) * 1978-10-02 1980-05-13 Eli Lilly And Company Peptides related to somatostatin
US4199500A (en) * 1978-11-20 1980-04-22 Eli Lilly And Company Peptides related to somatostatin
US4199501A (en) * 1978-11-20 1980-04-22 Eli Lilly And Company Peptides related to somatostatin
US4428942A (en) 1982-05-17 1984-01-31 The Salk Institute For Biological Studies Analogs of somatostatin
GB8423431D0 (en) * 1984-09-17 1984-10-24 Sandoz Ltd Organic compounds
SE8702550D0 (sv) * 1987-06-18 1987-06-18 Anders Grubb Cysteinproteashemmare
NO302481B1 (no) 1990-10-16 1998-03-09 Takeda Chemical Industries Ltd Polymer for et preparat med forlenget frigjöring, samt preparat med forlenget frigjöring
ES2110573T3 (es) 1992-08-07 1998-02-16 Takeda Chemical Industries Ltd Produccion de microcapsulas de farmacos solubles en agua.
EP0668073B1 (fr) * 1994-02-21 1999-04-14 Takeda Chemical Industries, Ltd. Matrice en polyester pour une préparation pharmaceutique à libération prolongée
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
CA2192782C (fr) 1995-12-15 2008-10-14 Nobuyuki Takechi Production de microsphere
US5908400A (en) * 1996-06-20 1999-06-01 Hisamitsu Pharmaceutical Co., Inc. Device structure for iontophoresis
US6309633B1 (en) 1999-06-19 2001-10-30 Nobex Corporation Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
US7169889B1 (en) 1999-06-19 2007-01-30 Biocon Limited Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
EP2062593A3 (fr) 2000-12-01 2011-08-17 Takeda Pharmaceutical Company Limited Procédé de production de préparation contenant un peptide bioactif
US7060675B2 (en) * 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6867183B2 (en) * 2001-02-15 2005-03-15 Nobex Corporation Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US6828305B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6858580B2 (en) * 2001-06-04 2005-02-22 Nobex Corporation Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US6713452B2 (en) 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6835802B2 (en) * 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US7312192B2 (en) * 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7196059B2 (en) 2001-09-07 2007-03-27 Biocon Limited Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7166571B2 (en) * 2001-09-07 2007-01-23 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US6913903B2 (en) * 2001-09-07 2005-07-05 Nobex Corporation Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
AU2003236521A1 (en) * 2002-06-13 2003-12-31 Nobex Corporation Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
EP2626368B1 (fr) * 2004-07-19 2016-12-21 Biocon Limited Conjugués insuline-oligomère, formulations et utilisations de ceux-ci
RU2453332C2 (ru) 2007-10-16 2012-06-20 Байокон Лимитид Твердая фармацевтическая композиция (варианты) и способ контроля концентрации глюкозы с ее помощью, способ получения твердой фармацевтической композиции (варианты), таблетка (варианты) и способ получения амфорных частиц
US20150157619A1 (en) 2012-07-10 2015-06-11 Takeda Pharmaceutical Company Limited Pharmaceutical preparation for injection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2608336A1 (de) * 1975-03-11 1976-09-30 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung
US4372884A (en) * 1975-08-06 1983-02-08 The Salk Institute For Biological Studies Pharmaceutically active peptides

Also Published As

Publication number Publication date
YU91578A (en) 1983-01-21
DD135900A5 (de) 1979-06-06
GB1596328A (en) 1981-08-26
NZ187009A (en) 1981-04-24
ZA782247B (en) 1979-12-27
IL54533A0 (en) 1978-07-31
PL114533B1 (en) 1981-02-28
FI781184A (fi) 1978-10-22
FR2387941B1 (fr) 1983-06-10
CA1113928A (fr) 1981-12-08
IT7822552A0 (it) 1978-04-20
CA1102315A (fr) 1981-06-02
PT67913A (en) 1978-05-01
NL7804218A (nl) 1978-10-24
RO81079A (fr) 1983-06-01
SU730295A3 (ru) 1980-04-25
AU3525378A (en) 1979-10-25
CH634039A5 (de) 1983-01-14
GR68945B (fr) 1982-03-29
RO76054A (fr) 1981-08-17
JPS53132588A (en) 1978-11-18
SU904519A3 (ru) 1982-02-07
IL54533A (en) 1982-11-30
DK174278A (da) 1978-10-22
PT67913B (en) 1979-11-14
HU177435B (en) 1981-10-28
DE2816854A1 (de) 1978-11-02
AR221699A1 (es) 1981-03-13
PL206280A1 (fr) 1980-01-02
ES469005A1 (es) 1979-09-01
BG28703A3 (en) 1980-06-16
RO81079B (ro) 1983-05-30
AU519275B2 (en) 1981-11-19
BE866117A (fr) 1978-10-19
AT361142B (de) 1981-02-25
IT1094462B (it) 1985-08-02
IE46868B1 (en) 1983-10-19
CS202096B2 (en) 1980-12-31
SE7804397L (sv) 1978-10-22
ATA282878A (de) 1980-07-15
ES476901A1 (es) 1979-10-16
PL115827B1 (en) 1981-05-30
US4100117A (en) 1978-07-11
FR2387941A1 (fr) 1978-11-17
FI64576B (fi) 1983-08-31
IE780765L (en) 1978-10-21

Similar Documents

Publication Publication Date Title
FI64576C (fi) Foerfarande foer framstaellning av en terapeutiskt anvaendbar somatostatinanalog
US4087390A (en) Somatostatin analogs and intermediates thereto
US4093574A (en) Somatostatin analogs and intermediates thereto
US4737487A (en) VIP type peptides
EP0000053B1 (fr) Analogues de la somatostatine, procédé pour leur préparation et des compositions pharmaceutiques les contenant
US4190648A (en) Peptides having somatostatin activity
KR20130127985A (ko) 글루코스-의존 인슐린 친화성 펩티드 유사체
US4490364A (en) CCK Agonists II
EP2460826B1 (fr) Composé peptidique de type motiline présentant une faculté d'absorption transmucosale qui lui est associée
EP0283956B1 (fr) Peptides atriaux natriurétiques contenant du fluor
US4162248A (en) Somatostatin analogs
WO1988003537A1 (fr) Nouveaux peptides
US4061626A (en) Somatostatin analogs and intermediates thereto
EP0000919B1 (fr) Analogues de somatostatine, leur procédé de préparation et leur utilisation comme produits pharmaceutiques.
EP0002264A1 (fr) Analogues de la somatostatine, leur procédé de préparation et leur composition pharmaceutique
KR900006711B1 (ko) 펩티드의 제조방법
EP0002262A1 (fr) Analogues de la somatostatine et leur procédé de préparation
US4076659A (en) L-Val10 -somatostatin and intermediates thereto
FI64575B (fi) Foerfarande foer framstaellning av en terapeutiskt anvaendbar somatostatinanalog
US4061607A (en) Somatostatin analogs and intermediates thereto
Bernard et al. Synthesis of conjugates between luteinizing hormone releasing hormone (LH‐RH) and N‐acetyl‐muramyl‐L‐alanyl‐D‐isoglutamine (MDP) models of totally synthetic vaccines
KR810000692B1 (ko) 소마토스타틴(Somatostatin) 동족체의 제조방법
KR850000151B1 (ko) 소마토스타틴 동족체의 제조방법
US3988308A (en) (Tyr3, Tyr14)-SRIF and intermediates
DK150618B (da) Analogifremgangsmaade til fremstilling af somatostatinanaloge eller farmaceutisk acceptable salte deraf

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: ELI LILLY AND COMPANY